Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erratum: Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment (Molecular psychiatry (2016))

Autor: Jukić, Marin, Opel, N., Ström, J., Carrillo-Roa, T., Miksys, S., Novalen, M., Renblom, A., Sim, S.C., Peñas-Lledó, E.M., Couvert, Philippe, Llerena, A., Baune, B.T., de Quervain, D.J., Papassotiropoulos, A., Tyndale, R.F., Binder, E.B., Dannlowski, U., Ingelman-Sundberg, Magnus

Publikováno v: Molecular Psychiatry

This corrects the article DOI: 10.1038/mp.2016.204.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4877::7ebd894e95cb82b20641d4332af7b455
https://hdl.handle.net/21.15107/rcub_farfar_2979

Nicotine metabolite ratio (3-Hydroxycotinine/Cotinine) in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation

Autor: Tanner, JA, Novalen, M, Jatlow, P, Huestis, MA, Murphy, SE, Kaprio, J, Kankaanpää, A, Galanti, L, Stefan, C, George, TP, Benowitz, NL, Lerman, C, Tyndale, RF

Publikováno v: Tanner, JA; Novalen, M; Jatlow, P; Huestis, MA; Murphy, SE; Kaprio, J; et al.(2015). Nicotine metabolite ratio (3-Hydroxycotinine/Cotinine) in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation. Cancer Epidemiology Biomarkers and Prevention, 24(8), 1239-1246. doi: 10.1158/1055-9965.EPI-14-1381. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4tg1k9hb

© 2015 American Association for Cancer Research. Background: The highly genetically variable enzyme CYP2A6 metabolizes nicotine to cotinine (COT) and COT to trans-30- hydroxycotinine (3HC). The nicotine metabolite ratio (NMR, 3HC/COT) is commonly us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4a7a14bcf2c52f5e5408917b2fca3e9d
http://www.escholarship.org/uc/item/4tg1k9hb

P.571 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

Autor: Milosavljević, F., Vučić, M., Manojlović, M., Ašujić, N., Batinić, B., Novalen, M., Miksys, S., Tyndale, R.F., Ingelman-Sundberg, M., Jukić, M.M.

Publikováno v: In European Neuropsychopharmacology December 2019 29 Supplement 6:S399-S400

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.